Millstone Evans Group, LLC Royalty Pharma PLC Transaction History
Millstone Evans Group, LLC
- $157 Billion
- Q3 2025
A detailed history of Millstone Evans Group, LLC transactions in Royalty Pharma PLC stock. As of the latest transaction made, Millstone Evans Group, LLC holds 98 shares of RPRX stock, worth $3,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
98
Previous 98
-0.0%
Holding current value
$3,778
Previous $3.53 Million
2.1%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RPRX
# of Institutions
509Shares Held
284MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.8 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY23MShares$888 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$844 Million0.14% of portfolio
-
Baillie Gifford & CO17.4MShares$670 Million0.48% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$470 Million0.45% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $16.9B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...